Kennondale Capital Management’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,144
Closed -$956K 84
2025
Q3
$956K Buy
20,144
+6,036
+43% +$292K 0.73% 60
2025
Q2
$753K Hold
14,108
0.77% 51
2025
Q1
$571K Sell
14,108
-14,109
-50% -$598K 0.62% 62
2024
Q4
$785K Buy
+28,217
New +$855K 0.85% 50

Other funds holding AKRO